21 research outputs found
Superconductors with Magnetic Impurities: Instantons and Sub-gap States
When subject to a weak magnetic impurity potential, the order parameter and
quasi-particle energy gap of a bulk singlet superconductor are suppressed.
According to the conventional mean-field theory of Abrikosov and Gor'kov, the
integrity of the energy gap is maintained up to a critical concentration of
magnetic impurities. In this paper, a field theoretic approach is developed to
critically analyze the validity of the mean field theory. Using the
supersymmetry technique we find a spatially homogeneous saddle-point that
reproduces the Abrikosov-Gor'kov theory, and identify instanton contributions
to the density of states that render the quasi-particle energy gap soft at any
non-zero magnetic impurity concentration. The sub-gap states are associated
with supersymmetry broken field configurations of the action. An analysis of
fluctuations around these configurations shows how the underlying supersymmetry
of the action is restored by zero modes. An estimate of the density of states
is given for all dimensionalities. To illustrate the universality of the
present scheme we apply the same method to study `gap fluctuations' in a normal
quantum dot coupled to a superconducting terminal. Using the same instanton
approach, we recover the universal result recently proposed by Vavilov et al.
Finally, we emphasize the universality of the present scheme for the
description of gap fluctuations in d-dimensional superconducting/normal
structures.Comment: 18 pages, 9 eps figure
Thigh-length compression stockings and DVT after stroke
Controversy exists as to whether neoadjuvant chemotherapy improves survival in patients with invasive bladder cancer, despite randomised controlled trials of more than 3000 patients. We undertook a systematic review and meta-analysis to assess the effect of such treatment on survival in patients with this disease
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines
In an effort to address potential cardiotoxicity liabilities identified with earlier frontrunner compounds, a number of new 3,5-diaryl-2-aminopyridine derivatives were synthesized. Several compounds exhibited potent antiplasmodial activity against both the multidrug resistant (K1) and sensitive (NF54) strains in the low nanomolar range. Some compounds displayed a significant reduction in potency in the hERG channel inhibition assay compared to previously reported frontrunner analogues. Several of these new analogues demonstrated promising in vivo efficacy in the P. berghei mouse model and will be further evaluated as potential clinical candidates. The SAR for in vitro antiplasmodial and hERG activity was delineate